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Abstract-I. The red blood cellhexose monophosphate shunt (HMS) and proteolytic responses to several
concentrations of Methylene Blue or sodium nitrite were measured.
2. The results suggested two distinct mechanisms for activation of the HMS: (I) nitrite treatment
increased HMS activity in response to oxidative challenge to red cellprotein; (2) Methylene Bluetreatment
activated HMS without injurious oxidative challenge. Nitrite-treated cells actively degraded protein,
whereas Methylene Blue-treated red cells did not activate proteolytic systems that degrade oxidized red
cell protein.
3. These observations are relevant to proposed in vitro systems for evaluation of drug hemolytic toxicity
potential on the basis of HMS stimulation capacity.

INTRODUCTION

Persons suffering from an inherent deficiency of red
cell glucose-6-phosphate dehydrogenase (G6PD) are
often susceptible to acute intravascular hemolysis
following treatment with certain drugs (Carson and
Frischer, 1966; Kirkman, 1968; Beutler, 1969). The
deficiency diminishes the ability of the erythrocyte
to accelerate the hexose monophosphate shunt
(HMS) and, therefore, to sustain adequate levels of
reduced nicotinamide adenine dinucleotide phosphate (NADPH) under oxidizing conditions (Gaetani
et al., 1974) (see Fig. 1). Since NADPH is required for
reduction of glutathione, and reduced glutathione
serves to detoxify peroxide and to protect protein
sulfhydryl groups from oxidation, G6PD-deficient
erythrocytes have a reduced ability to detoxify an
oxidative challenge (Fraser and Vessell, 1968; Kirkman et aI., 1975). Upon this basis many drug-induced
hemolyses have come to be regarded as a consequence of intracellular oxidative attack (Keller, 1971;
Gordon-Smith, 1980; Carson et al., 1981).
It has been proposed that the capability of a drug
to stimulate the HMS in normal red cells would
reflect a potential for hemolytic toxicity in G6PDdeficient erythrocytes (Welt et aI., 1971; Gaetani et
al., 1976; Pescarmona et al., 1982). Since it is not the
HMS per se that reverses oxidative damage, one must
presume that the elevation of HMS activity observed
under drug treatment is directly coupled to oxidative
challenge (i.e. to glutathione redox flux, see Fig. I) to
relate such predictions to oxidative toxicity. If mechanisms are operative through which the HMS may be
stimulated in the absence of oxidative challenge,

HMS stimulation would not necessarily be indicative
of drug toxicity.
Roth et al. (1975) and Carson et al. (1981), have
recognized at least two mechanisms through which
the HMS is activated in erythrocytes, one of which
appears to function independently of glutathione
redox flux. Some drugs activate the HMS in the
presence of a specific inhibitor of glutathione reductase, whereas other drugs fail to do so under the same
conditions. Carson et al. (1981) designated these
groups of compounds as "Methylene Blue-like" or
"ascorbate-like" respectively. The former group contained those compounds that maintained or increased
HMS activity in the presence of the inhibitor, and
the latter group contained compounds that did not
maintain elevated HMS activity under glutathione
reductase inhibition.
The results presented in the present report provide
additional support for the proposed existence of two
distinct HMS stimulation mechanisms, one of which
is independent of glutathione redox flux. The data on
proteolysis were particularly useful to this interpretation because the proteolytic system is activated
by oxidation of protein (Goldberg and Boches, 1982)
and, therefore, is a measure of real oxidative damage
to red cell protein.

METHODS

Proteolysis measurement

Buffers. Physiologically balanced salts solution (PBSS)
and phosphate buffered salts solution (PBS) were prepared
as described previously (Baird et al., 1984).
Reagents. Stock solutions of HMS stimulants; 250mM
sodium nitrite (reagent grade, Aldrich Chemical Co., Mil'The views expressed by the author do not reflect the views waukee, Wisconsin, U.S.A.) and 250J.lM Methylene Blue
of the Department of the Army or the Department of (3,7-bis(dimethylamino) pherothiazin-5-ium chloride, pharmaceutical grade, Mallinkrodt Chemical Works, St Louis,
Defense.
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Fig. I. The hexose monophosphate shunt and glutathione redox flux. Sequence A represents glutathione
mediated enzymatic reduction of hydrogen peroxide to water and sequence B represents the spontaneous
reduction of oxidized protein sulfhydryl groups, the two means by which glutathione protects red cells
against oxidative damage. GSH, reduced glutathione; GSSG, oxidized glutathione; P-SH, reduced protein
sulfhydryl; P-S. S-P, oxidized protein sulfhydryl; NADPH, reduced nicotinamide adenine dinucleotide
phosphate; NADP+, oxidized NADPH. (I) hexokinase; (2) glucose-6-phosphate dehydrogenase; (3)
glutathione reductase; (4) glutathione peroxidase; (5) 6-phosphogluconolactonase or spontaneous hydrolysis; (6) 6-phosphogluconate dehydrogenase.
Missouri, U.S.A.) were prepared as previously described
(Baird et al., 1984).
Reagents for tyrosine assay, l-nitroso-2-naphthol (reagent grade, Aldrich Chemical Co.) and nitric acid (Aldrich
Chemical Co.), were also prepared as described elsewhere
(Waalkes and Udenfriend, 1957).
Red blood cells. Twenty ml whole blood was drawn by
venipuncture from a 24-year-old Caucasian male and immediately washed and albuminized as reported previously
(Baird et al., 1984). Cycloheximide (Aldrich Chemical Co.)
was added to the red cell suspension (O°C) to 0.5 mM final
concentration to prevent incorporation of liberated tyrosine
into reticulocyte protein (Goldberg and Boches, 1982).
Concentration of RBC suspensions added to reaction mixtures were approximately those found in whole blood.
Incubation. Two ml PBSS containing 10mM D-glucose
(reagent grade, Sigma Chemical Co., St Louis, Missouri,
U.S.A.) served as the incubation medium. One ml of HMS
stimulant solution was added to the medium prior to
addition of I ml erythrocyte suspension. The incubation
vessels were 10 ml polystyrene screw-cap test tubes placed
horizontally at 3TC and ambient atmosphere for 30 min.
Incubation was terminated by addition of 4 ml cold (4°C)
30% trichloroacetic acid. Acid treated samples were stored
at 4°C overnight.
Tyrosine assay. Acid-treated samples were centrifuged at
1600g for 10 min. Two ml of supernatant were placed in a
50 ml polypropylene centrifuge tube (Falcon 2070 Tube,
Beckton, Dickinson and Co., Oxnard, California, U.S.A.)
followed by addition of I ml nitroso-naphthol reagent and
finally I ml nitric acid solution. The reaction mixture was
placed in a 55°C water bath for 30 min. Immediately
following incubation, solutions were cooled to room temperature and 10 ml ethylene dichloride (spectrophotometric
grade, Aldrich Chemical Co.) were added. Mixtures were
shaken vigorously for about 10 sec and centrifuged at 1600g
for 10min. Two ml of the aqueous layer were removed for
spectrophotofluorometric measurement of the tyrosinenaphthol complex in an Aminco Bowman spectrophotofluorometer. Excitation wavelength was set at 465 nm and

emission intensity was measured at 565 nm as described
previously (Waalkes and Udenfriend, 1957).
HMS activity measure
HMS activity was measured, with correction for glucose
carbon recycling through the shunt, as described previously
(Baird et al., 1984). To estimate the possible influence of
0.5 mM cycloheximide upon HMS stimulation induced by
Methylene Blue or sodium nitrite, cycloheximide-treated red
cells were treated separately with these compounds as
described above for measurement of proteolysis and HMS
activities.
Statistical analysis
Statistical analyses were conducted as previously described (Baird et al., 1984).

RESULTS

Proteolysis measurements
Release of tyrosine from red cells in the presence
of increasing concentrations of Methylene Blue or
sodium nitrite is shown in Fig. 2. Tyrosine concentrations of non-treated erythrocyte suspensions averaged 3 nmol/rnl. This was taken to represent tyrosine
from sources other than oxidant-induced proteolysis
(see "Discussion") and was set to equal a baseline
proteolytic activity of zero.
Methylene Blue induced no proteolytic activity
under any test conditions. Nitrite-treated cells
released tyrosine at maximum rates of 25 and
24nmol'ml RBC-l'hr- l with 20 and 40mM
NaN0 2 , respectively. Proteolytic activity was observed at 5, but not 2.5 mM NaN0 2 • Treatment
groups were run in duplicate and on two separate
occasions. The results obtained in these experiments
were in good agreement.

Red cell HMS activity and oxidant stress
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Fig. 2. Proteolytic activity in red cell suspensions treated
with sodium nitrite (e) or with Methylene Blue (0) as
determined by monitoring the proteolytic release of tyrosine
from erythrocyte protein by spectrophotofluorometric
assay.

HMS activity measurements

Stimulation of HMS activity by sodium nitrite is
shown in Fig. 3. Increases in activity between 0,
0.625, 1.88 and 2.50 mM NaN0 2 were significant
(p < 0.001). HMS activity became maximal at
approx. 65 activity units (nmol CO 2 trapped' ml
RBC- 1 • hr- 1) in red cells treated with between 10 and
20 mM NaN0 2• The difference between these means
was insignificant (P > 0.1). The 37% decrease in
activity between 20 and 80 mM NaN0 2 was
significant (P < 0.001). Appreciable hemolysis was
not observed in any NaN0 2-treated RBC suspension.
Stimulation of HMS activity by Methylene Blue is
shown in Fig. 3. The rate of activity reached a
maximum at approx. 120 activity units following
treatment with between 10 and 80,uM Methylene
mM NaN0 2
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Fig. 3. Hexose monophosphate shunt (HMS) activity in red
cell suspensions treated with sodium nitrite (mM (e» or
with Methylene Blue (pM (0». The data points are the sum
of activity measurements for both primary HMS activity
and HMS activity due to glucose carbon recycling through
the HMS in which means were obtained from replicate sets
of 10 samples each. Brackets indicate the limits for the 95%
confidence interval.
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Blue, as evidenced by the insignificant (P > 0.05)
differences among these means.
Based on calculation from maximal HMS activities
with minimal oxidant concentration, 200 mol NaN0 2
are required to stimulate the HMS to release 1 mol
CO 2 , Methylene Blue, however, induced the HMS to
release 160 mol CO 2 per mol Methylene Blue. Thus,
on a molar basis, Methylene Blue chloride is
3.2 x 104-fold more potent an HMS stimulant than
sodium nitrite.
These experiments were conducted on two separate
occasions (data not given) and the activity means
were not significantly different (P > 0.05) from those
given herein. Differences between the HMS activity
means of cycloheximide-treated and non-treated red
cells were insignificant (P > 0.05) in the absence and
presence of HMS activity-saturating concentrations
of sodium nitrite or Methylene Blue (data not given).
DISCUSSION

Measurements of proteolytic and HMS activities
have been used to characterize red blood cell responses to sodium nitrite and to Methylene Blue
chloride. The responses to sodium nitrite were consistent with those expected from injurious oxidative
attack. Methylene Blue treated red cell suspensions,
however, did not respond similarly. The results
indicate that HMS stimulation observed under
Methylene Blue treatment occurs in the absence of
a nitrite-like oxidative attack. This observation is
relevant to proposed in vitro systems which would
evaluate drug potential for hemolytic toxicity in
G6PD-deficient persons based upon capacity of drug
for HMS stimulation.
Oxidation of protein sulfhydryl groups can result
in loss of functional protein conformation. Reduced
glutathione (GSH) is a highly reactive peptide
(v-t-glutamyl-r-cysteinylglycine) which serves to
guard against such events through two means: (I)
direct reduction of oxidized protein sulfhydryls; (2)
enzymatic detoxification of hydrogen peroxide which
may otherwise oxidize protein sulfhydryls and generate oxidizing radicals (Beutler, 1980; Srivastava et al.,
1980). As an intracellular oxidative potential is increased, the GSH oxidation rate is accelerated and
NADPH is consequently more rapidly oxidized to
NADP+ in catalysis of oxidized glutathione (GSSG)
reduction (Kirkman et al., 1980). When the oxidative
potential is of such magnitude that the rate of
production of GSSG exceeds that of GSH, the latter
will become depleted and oxidation of protein may
more readily occur (Srivastava et al., 1980). These
reactions are directly coupled to the HMS (see
Fig. I).
The recent report by Goldberg and Boches (1982)
has revealed the existence of an ATP-dependent
proteolytic system in mature red cells that is activated
in the presence of abnormal protein side group
moeities, such as those generated during oxidative
attack. In the present study, activity of this proteolytic system has been measured to provide an estimate
of oxidative damage to erythrocyte cytoplasm. In
accordance with the processes described in the paragraph above, it may reasonably be presumed that
activation of the proteolytic system would occur only
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when intracellular GSH has been depleted. That is,
in the presence of a high GSH/GSSG ratio, protein
would be protected against oxidation and the proteolytic system would remain inactive. It is thus evident
that a proteolytic response is indicative of failure of
the glutathione redox system to prevent an injurious
oxidative attack.
The nitrite-HMS activation plot (Fig. 3) and the
nitrite-induced proteolytic responses (Fig. 2) are consistent with a generalized oxidative attack. The slow
initial rate ofHMS activation seen in Fig. 3 probably
reflects a buffering effect provided by the very high
ambient GSH/GSSG ratio (Beutler, 1980), i.e. the
oxidation potential introduced by 2.5 mM or less
NaN0 2 (Fig. 3) appears to have been effectively
reduced without causing an appreciable accumulation of NADP+ (i.e. HMS stimulation). On the other
hand, 5 mM NaN0 2 (Fig. 3) generated peroxide
(Cohen et al., 1964) and oxidized protein at a rate
which probably elicited GSH oxidation in sufficient
quantity to increase demand for NADPH to a level
which could not be immediately satisfied. The result
would be a fall in the NADPH/NADP+ ratio and
subsequent HMS stimulation (Gaetani et al., 1974;
Kirkman et al., 1980).
The nitrite-induced proteolysis responses are consistent with this interpretation. In Fig. 2 one may see
that concentrations of nitrite below HMS activity
saturation potential did not induce proteolysis and
thus appear to have not exhausted the reduction
potential of GSH. At nitrite concentrations of 10 mM
and above (at and above HMS activity maximum, see
Fig. 3) proteolytic activity was observed. This effect
may be interpreted quantitatively as a response to
oxidative attack; at maximal HMS activity levels the
NADPH/NADP+ ratio is very low (Kirkman et al.,
1980) so that effective GSH protection against
oxidation may be lost and oxidative denaturation of
erythrocyte protein would occur (Srivastava et al.,
1980), thus creating substrate for the ATP-dependent
proteolytic system. Decreases observed inHMS
activity between 20 and 80 mM NaN0 2 may be the
result of oxidative/proteolytic decomposition of red
cells.
Red cells treated with Methylene Blue did not
respond as would be expected after exposure to an
injurious oxidative potential. If the Methylene
Blue-induced HMS stimulation was elicited for the
purpose of protection against a potentially toxic
oxidative challenge, 0.625 JiM Methylene Blue would
have to introduce an intracellular oxidizing potential
equivalent to that introduced by 5 mM NaN0 2
because at both of these concentrations the HMS
was elevated to approx. 30 activity units. This seems
improbable because nitrite has an oxidation potential
(1.0 volt) much greater than that of fully oxidized
Methylene Blue (0.065 volt) (Long, 1961). Despite the
more powerful oxidation potential nitrite possesses,
Methylene Blue was remarkably more effective in
inducing glucose catabolism through the HMS (3.2
x l Ot-fold). The relatively potent effect of Methylene
Blue on HMS activity must be due to its ability to
accept electrons from NADPH via diaphorase II
(Harvey and Kaneko, 1977). In this manner Methylene Blue may induce HMS stimulation through
generation of NADP+ (Gaetani et al., 1974) and

subsequent activation of G6PD (Kirkman et al
1980). Metz et al. (1976) demonstrated that hem~~
globin was an effective electron acceptor for the
reduced Methylene Blue (Leukomethylene Blue)
product of diaphorase II activity. Thus, minute
quantities of Methylene Blue may be continuously
reduced and oxidized to effect a strong HMS response (Harvey and Kaneko, 1977). This autoxidative process has been described as oxidatively stressful (Gaetani et al., 1974; Metz et al., 1976) because
this reaction with hemoglobin may result in formation of superoxide which may gain electrons in its
spontaneous reduction to water (Srivastava et al.,
1980). This process (superoxide formation) has been
documented in the reaction of nitrite with oxyhemoglobin (Tomada et al., 1981; Doyle et al., 1982).
In general, if electrons for superoxide reduction are
obtained randomly from oxidatively labile groups in
the erythrocyte, rather than GSH, an oxidative attack
results (Srivastava et al., 1980). Thus, if the redox flux
of Methylene Blue generated toxic quantities of
oxidizing radicals, oxidative denaturation of red cell
protein would be expected. The proteolysis measurements under Methylene Blue treatment do no support
this interpretation. The absence of proteolysis in
Methylene Blue-treated red cells (Fig. 2) suggests that
the dye (and the hypothesized .oxidation potential
held in intracellular oxygen) did not challenge oxidatively labile protein groups even at concentrations
as much as 8-fold in excess of that required for HMS
activity saturation. These observations demonstrate
that Methylene Blue-induced stimulation of the HMS
is not associated with a toxic accumulation of oxygen
radicals.
The trivial explanation for the absence of proteolytic activity in Methylene Blue-treated red cells
might be that the dye either inhibited the proteolytic
system or chemically interfered with recovery/
measurement of the tyrosine-naphthol complex used
to quantify proteolytic activity. These possibilities
were considered unlikely, however, because in experiments in which Methylene Blue (12.5 JiM) was added
with 20 mM NaN0 2 red cell suspensions, no diminution of proteolytic activity was observed (data not
given).
Data of previous studies suggest that Methylene
Blue-induced HMS stimulation may occur in the
absence of toxic oxidative challenge. Red cells treated
with Methylene Blue, at concentrations comparable
to those employed in this study, accumulate rather
than consume GSH (Bockris and Smith, 1962; Jacob
and Jandl, 1966). Also, these concentrations of
Methylene Blue do not generate detectable levels
of HP2 (Smith and Mahaffey, 1977; Harvey and
Kaneko, 1976). The data of Carson et al. (1981)
discussed in the introduction to this report are also
consistent with this interpretation; i.e. Methylene
Blue-induced elevation of HMS activity was independent of GSH redox flux. Since Methylene Bh:e
activates the HMS without introduction of a toXIC
oxidation potential, this HMS stimulation does ~ot
appear to be related to defense against oxidatIVe
injury.
This study has demonstrated that there exists at
least one mechanism through which the red cell HMS
activity level may become elevated in the absence of
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a toxic oxidizing potential. Thus, HMS stimulation
capacity of a drug may not serve as a reliable
indicator of "hemolytic toxicity", as has been suggested (Welt et al., 1971; Gaetani et al., 1976;
Pescarmona et al., 1982). It would appear that those
compounds designated "Methylene Blue-like" by
Carson et al. (1981) may elicit HMS activity elevation
without toxic oxidation and, therefore, may be
unsuitable for use in hemolytic toxicity screening
procedures utilizing the HMS stimulation capacity
criterion.
In this regard, whether or not certain hemolytic
drugs behave like Methylene Blue or sodium nitrite
is an important question. Primaquine, a widely used
antimalarial with known hemolytic toxicity, is a case
in point. Cohen and Hochstein (1964) reported that
this compound generated H 20 2 in human red cells
incubated in vitro, which would suggest sodium
nitrite-like oxidative behavior. However, Kelman et
al. (1982), have recently demonstrated that although
primaquine does generate H 20 2 , primaquine-induced
HMS stimulation is independent from H 20 2 generation and glutathione redox flux. The authors
pointed out that primaquine appears to stimulate the
HMS in much the same manner as Methylene Blue.
Similarly, we have reported that two putative metabolites of primaquine (hydroxylated) show Methylene
Blue-like oxidative activity in G6PD-normal and
deficient red blood cells in vitro; potent HMS stimulation without causing proteolysis, and an ability to
oxidize NADPH directly and via diaphorase II (Baird
et al., 1983). These findings suggest that evaluation of
8-aminoquinoline antimalarial drugs for hemolytic
toxicity based on capacity for HMS stimulation in
vitro may be unsatisfactory. Specifically, primaquineinduced HMS stimulation may not be correlated to
realized oxidative challenge to red cell protein.
SUMMARY

Data are presented which demonstrate that
levation of HMS activity by red blood cells may
ot be correlated to erythrotoxic oxidative processes
priori. In vitro measurements of the activity of a
ently described proteolytic system, which rapidly
egrades oxidized proteins in mature red blood cells,
ere employed to determine the extent of oxidative
njury incurred during exposure to two HMS stimunts, sodium nitrite and Methylene Blue chloride.
MS activity was measured by quantitation of
CO 2 from glucose radioisotopes added to red cell
uspensions. The levels of proteolytic and HMS
ctivities elevated by sodium nitrite appeared closely
elated; low levels of HMS activity ( < lO-fold elevaion) were not associated with detectable proteolytic
ctivity, but with increasing HMS activity (> IS-fold
levation) proteolysis was evident. Even though
ethylene Blue elevated HMS activity by as much as
5-fold, concentrations of this stimulant in as much
8-fold excess of that required to induce this level
HMS activity (higher concentrations were not
amined) did not cause proteolysis. It is thus evident
at elevation of HMS activity is not necessarily
lated to toxic intracellular oxidative stress. Thus,
roposed systems which would evaluate the oxidative
oXicity of certain compounds on the basis of their

effect on the red blood cell HMS in vitro may be
inappropriate. Primaquine, a hemolytically toxic antimalarial drug, has been examined in such systems
and the fact that it is capable of HMS stimulation has
been cited as indicative of its oxidative toxicity.
Recent reports discussed herein suggest that the
primaquine effect on the HMS is essentially Methylene Blue-like, and therefore estimations of its toxicity
made on this criterion would appear invalid.
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